Specialist consultant prescribed medicinal cannabis

That this House recognises the benefits of prescribed medical cannabis by a specialist consultant for people suffering with chronic pain, epilepsy and a variety of other conditions; welcomes the legalisation around the use of prescribed medical cannabis on 1 November 2018; but regrets the difficulties that patients and their families continue to face in accessing prescribed medical cannabis that their consultants have prescribed through the NHS; further regrets the restrictive NHS guidelines that prevent most patients from accessing it and deter specialist consultants from prescribing it; condemns the two-tier system that this has created where only people who can afford to pay for the prescription have easy and ready access to prescribed medical cannabis; and calls on the Government to use every means necessary to ensure that NHS patients have easy access to prescribed medical cannabis should their specialist consultant prescribe it for them